-
1 Comment
EMIS Group plc is currently in a long term uptrend where the price is trading 6.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
EMIS Group plc's total revenue sank by 0.0% to $40M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $6M since the same quarter in the previous year.
Finally, its free cash flow grew by 23.5% to $11M since the same quarter in the previous year.
Based on the above factors, EMIS Group plc gets an overall score of 3/5.
Exchange | LSE |
---|---|
CurrencyCode | GBP |
ISIN | GB00B61D1Y04 |
Sector | Healthcare |
Industry | Health Information Services |
Dividend Yield | 2.1% |
---|---|
Beta | -0.13 |
Market Cap | 1B |
PE Ratio | 40.85 |
Target Price | 1623.24 |
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EMIS.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025